We are a charity and rely on donations

Charity Number: 1117194 (England and Wales)

Registered Company: 06000961

Registered address:
Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom

London office:
Shift.ms, Somerset House, Strand, West Goods Entrance, London WC2R 1LA, United Kingdom

©2024 Shift.ms

@FreddyGiguere 

Last reply

FreddyGiguere

Ocrevus infusion

Hey, so I'm just about to go on a medical trial in Canada for new ms med, but first they are switch me to ocrevus infusion. Any one have information on this med for positive or negative effects?
12
@marilynlowery
@marilynlowery
 

Ocrelizumab (Ocrevus). This humanized immunoglobulin antibody medication is the only DMT approved by the FDA to treat both the relapse-remitting and primary progressive forms of MS. Clinical trials showed it reduced relapse rate in relapsing disease and slowed worsening of disability in both forms of the disease. Ocrevus is given via an intravenous infusion by a medical professional. Side effects may infusion-related reactions including irritation at the injection site, low blood pressure, fever, and nausea among others. Ocrevus may also increase the risk of some types of cancer, particularly breast cancer. I am sure that you have, by now, seen this. But, just in case, I copied and pasted for you. Good luck!!!

@FreddyGiguere
@FreddyGiguere
 

@marilynlowery Ya I've read that but thanks a bunch :) 👍